Skip to main content
Clinical Trials/ISRCTN81574253
ISRCTN81574253
Completed
N/A

Brain development, brain functioning, growth and metabolic aspects in the clinical management of transsexual adolescents

Vrije University Medical Centre (VUMC) (The Netherlands)0 sites264 target enrollmentMay 2, 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Transsexuality
Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)
Enrollment
264
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Abstract results in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17074986 2017 Results article in https://pubmed.ncbi.nlm.nih.gov/28419243/ (added 06/08/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32909025/ (added 06/08/2021) 2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23433223/ (added 06/08/2021) 2015 Results article in https://pubmed.ncbi.nlm.nih.gov/25720349/ (added 06/08/2021) 2016 Results article in https://pubmed.ncbi.nlm.nih.gov/27318023/ (added 06/08/2021)

Registry
who.int
Start Date
May 2, 2007
End Date
December 31, 2009
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria \- pubertal patients:
  • 1\. Girls and boys with transsexualism who are eligible for sex reassignment according to psychologist and psychiatrist (if they are older than 12 years, psychologically stable and live in a stable social environment)
  • 2\. Girls have to be in stage B2 and boys in G2\-G3 with measurable oestradiol and testosterone levels respectively
  • Inclusion criteria \- pre\-pubertal patients:
  • 1\. Girls and boys with high probability of transsexualism according to psychologist or psychiatrist and the age of 9 to 12 years
  • 2\. Girls have to be in an earlier stage than B2 and boys in an earlier stage than G2\-G3
  • Inclusion criteria \- healthy subjects:
  • 1\. Girls and boys who are similar aged friends of the transsexual patients

Exclusion Criteria

  • Exclusion criteria \- patients:
  • 1\. Intersex conditions
  • Exclusion criteria \- healthy subjects:
  • 1\. Puberty delaying treatment or hormonal therapy; oral anticonception users are not excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials